Edition:
India

Edesa Biotech Inc (EDSA.OQ)

EDSA.OQ on NASDAQ Stock Exchange Capital Market

3.82USD
1:30am IST
Change (% chg)

$-0.22 (-5.45%)
Prev Close
$4.04
Open
$4.04
Day's High
$4.04
Day's Low
$3.82
Volume
2,342
Avg. Vol
152,463
52-wk High
$13.56
52-wk Low
$0.76

Latest Key Developments (Source: Significant Developments)

Edesa Biotech Says Qtrly Loss Per Share $0.30
Thursday, 15 Aug 2019 

Aug 14 (Reuters) - Edesa Biotech Inc ::EDESA BIOTECH INC - REPORTS QUARTERLY FINANCIAL RESULTS.EDESA BIOTECH INC - QTRLY LOSS PER SHARE $0.30.  Full Article

Lumira Capital Investment Management Reports A 24.7% Stake In Edesa Biotech As Of June 7
Tuesday, 18 Jun 2019 

June 17 (Reuters) - Lumira Capital Investment Management Inc::LUMIRA CAPITAL INVESTMENT MANAGEMENT INC REPORTS A 24.7% STAKE IN EDESA BIOTECH INC <<>> AS OF JUNE 7, 2019 - SEC FILING .  Full Article

Stellar Biotechnologies Reports Second Quarter Loss Per Share Of $0.31
Wednesday, 8 May 2019 

May 8 (Reuters) - Stellar Biotechnologies Inc ::STELLAR BIOTECHNOLOGIES REPORTS SECOND QUARTER FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.31.TOTAL REVENUES INCREASED BY $0.06 MILLION TO $0.12 MILLION FOR THREE MONTHS ENDED MARCH 31, 2019.  Full Article

Stellar Biotechnologies Q1 Loss Per Share $0.26
Wednesday, 6 Feb 2019 

Stellar Biotechnologies Inc ::STELLAR BIOTECHNOLOGIES REPORTS FIRST QUARTER FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.26.  Full Article

Stellar Biotechnologies - Ended Fiscal Year With More Than $10 Mln In Cash & Short-Term Investments
Friday, 30 Nov 2018 

Nov 30 (Reuters) - Stellar Biotechnologies Inc ::STELLAR BIOTECHNOLOGIES REPORTS FISCAL YEAR 2018 FINANCIAL RESULTS.STELLAR BIOTECHNOLOGIES INC - ENDED FISCAL YEAR WITH MORE THAN $10 MILLION IN CASH AND SHORT-TERM INVESTMENTS.  Full Article

Stellar Biotechnologies Announces Pricing Of $5.5 Mln Public Offering
Friday, 11 May 2018 

May 11 (Reuters) - Stellar Biotechnologies Inc ::STELLAR BIOTECHNOLOGIES ANNOUNCES PRICING OF $5.5 MILLION PUBLIC OFFERING.STELLAR BIOTECHNOLOGIES INC - STELLAR IS OFFERING UNITS AT A PRICE OF $2.65 PER UNIT.STELLAR BIOTECHNOLOGIES INC - ANNOUNCED PRICING OF A PUBLIC OFFERING OF AN AGGREGATE OF 2.1 MILLION UNITS.  Full Article

Stellar Biotechnologies Reports Q1 Loss Per Share $0.13
Thursday, 8 Feb 2018 

Feb 7 (Reuters) - Stellar Biotechnologies Inc ::STELLAR BIOTECHNOLOGIES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.13.‍TOTAL REVENUES FOR QUARTER ENDED DECEMBER 31, 2017 WERE $.02 MILLION COMPARED TO $.14 MILLION FOR SAME PERIOD IN 2016​.  Full Article

No consensus analysis data available.